An Open-Label, Single-Arm, Phase II Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Central Nervous System Progression Post-Radiotherapy in Patients With HER2-Positive Metastatic Breast Cancer (PATRICIA)

Investigator: Jenny Chang, MD

Study Coordinator: Lacey Burey

Status: Open Not Enrolling Number: NCT02536339

Phone: 713.441.1159

Protocol Number: Pro00013401


This study will examine the safety and efficacy of pertuzumab in combination with high-dose trastuzumab in adult participants with HER2-positive MBC with CNS metastases and disease progression in the brain following radiotherapy.
More to Explore
Live Chat Available